INO vs GILD: Which Stock is Better?
Side-by-side comparison of Inovio Pharmaceuticals Inc and Gilead Sciences Inc in 2026
INO
Inovio Pharmaceuticals Inc
$1.19
GILD
Gilead Sciences Inc
$139.77
Key Metrics Comparison
| Metric | INO | GILD | Winner |
|---|---|---|---|
| Market Cap | $90.57M | $174.33B | GILD |
| P/E Ratio | N/A | 20.72 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | -82857.4% | 78.8% | GILD |
Analyze INO
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INO or GILD a better investment?
Comparing INO and GILD: Inovio Pharmaceuticals Inc has a market cap of $90.57M while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INO and GILD?
INO (Inovio Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INO or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INO or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for INO.
Which company is more profitable: INO or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -82857.4% for INO.
Which is the larger company: INO or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $90.57M for INO.
Should I buy INO or GILD in 2026?
Both INO and GILD have investment merit. INO trades at $1.19 while GILD trades at $139.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INO and GILD stock?
Key differences: Market Cap ($90.57M vs $174.33B), P/E Ratio (N/A vs 20.7x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-82857.4% vs 78.8%).